PRELIMINARY COMMUNICATION FOR RAPID COMMUNICATION OF PRELIMINARY DATA
Association of HIV/AIDS and COVID-19 variables: an ecological study
 
More details
Hide details
1
Department of Environmental Health Engineering, School of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
 
2
Health Sciences Research Center, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
 
3
Department of Nursing, School of Nursing and Midwifery, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
 
4
Department of operating room and anesthesia, Neyshabur University of Medical Sciences, Neyshabur, Iran
 
5
Student Research Committee, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
 
 
Submission date: 2021-03-09
 
 
Final revision date: 2021-03-26
 
 
Acceptance date: 2021-03-26
 
 
Publication date: 2021-06-30
 
 
HIV & AIDS Review 2021;20(2):71-77
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The coronavirus disease 2019 (COVID-19) has become the greatest critical healthcare concern in 2020. The present study investigated the correlation between COVID-19 distribution and the prevalence of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) among countries.

Material and methods:
Data were obtained from publicly available data on COVID-19 and HIV/ AIDS, such as the World Health Organization (WHO) and Global Burden of Disease (GBD). Bivariate correlation analyses were used to investigate the correlation between the variables.

Results:
COVID-19 cases and death ratio negatively correlated with the  prevalence of  HIV/AIDS (r = –0.40 and r = –0.38, p < 0.05, respectively).

Conclusions:
The findings indicated that in countries with high prevalence of HIV/ AIDS, COVID-19 cases and death ratio were low, which could be due to the type of therapy or screening system. Nevertheless, further studies are required in this field.

 
REFERENCES (38)
1.
World Health Organization. Coronavirus disease 2019 (COVID-19):.
 
2.
situation report, 72. 2020.
 
3.
Taherizadeh M, Tabibzadeh A, Panahi M, et al. An introduction to SARS Coronavirus 2; Comparative analysis with MERS and.
 
4.
SARS coronaviruses: a brief review. Iranian J Public Health 2020; 49 (Suppl 1).
 
5.
Worldometer. COVID-19 Coronavirus Pandemic. 2020. Available from: https://www.worldometers.info/...?.
 
6.
Sohrabi C, Alsafi Z, O'Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71-76.
 
7.
Mirzaei H, McFarland W, Karamouzian M, Sharifi H. COVID-19 among people living with HIV: a systematic review. AIDS Behav 2020; doi: 10.1007/s10461-020-02983-2 [Epub ahead of print].
 
8.
Lee LY, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and The effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol 2020; 21: 1309-1316.
 
9.
Cooper TJ, Woodward BL, Alom S, Harky A. Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review. HIV Med 2020; doi: 10.1111/hiv.12911 [Epub ahead of print].
 
10.
Sepandi M, Taghdir M, Alimohamadi Y, Afrashteh S, Hosamirudsari H. Factors associated with mortality in COVID-19 patients: a systematic review and meta-analysis. IranJ Public Health 2020; 49: 1211-1221.
 
11.
Chang CC, Crane M, Zhou J, et al. HIV and co‐infections. Immunol Rev 2013; 254: 114-142.
 
12.
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in The New York City area. JAMA 2020; 323: 2052-2059.
 
13.
Borobia AM, Carcas AJ, Arnalich F, et al. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J Clin Med 2020; 9: 1733.
 
14.
Karmen-Tuohy S, Carlucci PM, Zervou FN, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr 2020; 85: 6-10.
 
15.
Mondi A, Cimini E, Colavita F, et al. COVID‐19 in people living with HIV: clinical implications of dynamics of the immune response to SARS‐CoV‐2. J Med Virol 2021; 93: 1796-1804.
 
16.
Tian C, Tang L, Wu J, et al. An HIV-infected patient with coronavirus disease 2019 has a favourable prognosis: a case report. Ann Palliat Med 2021; 10: 5808-5812.
 
17.
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. 2020. Available from: http://ghdx.healthdata.org/gbd....
 
18.
World_Bank. World Bank Country and Lending Groups. 2019. Available from: https://datahelpdesk.worldbank....
 
19.
UNDP. Human Development Reports. 2018. Available from: http://hdr.undp.org/en/composi....
 
20.
Xu Z, Yu D, Yin X, Zheng F, Li H. Socioeconomic status is associated with global diabetes prevalence. Oncotarget 2017; 8: 44434-44439.
 
21.
Lakshmi Priyadarsini S, Suresh M. Factors influencing the epidemiological characteristics of pandemic COVID 19: a TISM approach.
 
22.
Int J Healthcare Manag 2020; 13: 89-98.
 
23.
Paul R, Arif AA, Adeyemi O, Ghosh S, Han D. Progression of.
 
24.
COVID‐19 from urban to rural areas in the United States: a spatiotemporal analysis of prevalence rates. J Rural Health 2020; 36: 591-601.
 
25.
Peters DJ. Community susceptibility and resiliency to COVID-19 across the rural-urban continuum in the United States. J Rural.
 
26.
Health 2020; 36: 446-456.
 
27.
Mehri A, Alimohamadi Y, Mohammadi M, Sepandi M, Khodamoradi F, Eesmaeilzadeh F. Trend of HIV and tuberculosis co-.
 
28.
epidemics in different regions of World Health Organization during 2003-2017. HIV AIDS Rev 2020; 19: 167-171.
 
29.
Aristide C, Okello S, Bwana M, Siedner MJ, Peck RN. Learning from people with HIV: their insights are critical to our response to The intersecting COVID-19 and HIV pandemics in Africa. AIDS Behav 2020; doi: 10.1007/s10461-020-02955-6 [Epub ahead of print].
 
30.
Carrico AW, Horvath KJ, Grov C, et al. Double jeopardy: methamphetamine use and HIV as risk factors for COVID-19. AIDS Behav 2020; 24: 3020-3023.
 
31.
Nkengasong J. Let Africa into the market for COVID-19 diagnostics. Nature 2020; 580: 565.
 
32.
Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The burden of COVID-19 in people living with HIV: a syndemic perspective. AIDS Behav 2020; 24: 2244-2249.
 
33.
Del Amo J, Polo R, Moreno S, et al. Incidence and severity of.
 
34.
COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med 2020; 173: 536-541.
 
35.
Blanco JL, Ambrosioni J, Garcia F, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV 2020; 7: e314-e316.
 
36.
Pence BD. Severe COVID-19 and aging: are monocytes the key? Geroscience 2020; 42: 1051-1061.
 
37.
Lim WS, Liang CK, Assantachai P, et al. COVID-19 and older people in Asia: Asian Working Group for Sarcopenia calls to action. Geriatr Gerontol Int 2020; 20: 547-558.
 
38.
Chen M, An W, Xia F, et al. Clinical characteristics of rehospitalized patients with COVID-19 in China. J Med Virol 2020; 92: 2146-2151.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top